FOXO3 and breast carcinoma: Although in breast cancer, a repressive effect of FOXO3 on VEGF was reported [42], we observed that NB15/FOXO3 cells per se expressed higher levels of fully processed VEGF-C and hypoxia further induced the unprocessed VEGF-C variant at 58/61 kDa.